Sinocare Challenges Abbott's Glucose Monitor Patents
Chinese medical device maker Sinocare has denied Abbott's allegations that it is infringing two patents protecting technology that continuously monitors glucose levels in diabetes patients, arguing that the patents were invalid....To view the full article, register now.
Already a subscriber? Click here to view full article